Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Pfizer in court over Chinese stealing trade secrets

<< Previous

Bullboard Posts

Next >>

Comment by itntdfon Feb 08, 2023 2:28pm

138 Views

Post# 35275113

RE:RE:RE:RE:RE:Pfizer in court over Chinese stealing trade secrets

when you say:
I would also think that Adlai Nortye had willing "surrendered" their licensing agreement with ONCY knowing that ONCY would be acquired by Big Pharma

what would cause you to think that? nothing in your posted link even suggests that.

<< Previous

Bullboard Posts

Next >>

Who, why, and what of the great "Crypto Surge"